ロード中...
Comparative effectiveness of an angiotensin receptor blocker, olmesartan medoxomil, in older hypertensive patients
The efficacy and safety of olmesartan medoxomil (OM) vs active control (AC) monotherapy among elderly patients aged 60‐79 years (N = 4487) was evaluated by meta‐analysis (25 studies). In all patients, change from baseline to end point in blood pressure (BP) was significantly greater with OM vs AC (−...
保存先:
| 出版年: | J Clin Hypertens (Greenwich) |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8031060/ https://ncbi.nlm.nih.gov/pubmed/29462508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13183 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|